Edition:
United States

Insider Trading: Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

8.10USD
30 Sep 2016
Change (% chg)

$0.17 (+2.14%)
Prev Close
$7.93
Open
$7.98
Day's High
$8.15
Day's Low
$7.89
Volume
1,095,631
Avg. Vol
1,460,389
52-wk High
$10.95
52-wk Low
$5.57

All Insider Trades
Trading Date Name Title Type Shares Traded Price
29 Dec 2015

Apelian (David)

Officer Buy 10,000 $3.02
29 Dec 2015

Apelian (David)

Officer Sell 10,000 $10.50
27 Dec 2015

Fenton (Mary Kay)

Chief Financial Officer Buy 43,500 $1.05
27 Dec 2015

Fenton (Mary Kay)

Chief Financial Officer Sell 43,500 $10.08
10 Nov 2015

Vitullo (Nicole)

Director Sell 49,630 $10.31
10 Nov 2015

Vitullo (Nicole)

Director Sell 370 $10.31
9 Nov 2015

Vitullo (Nicole)

Director Sell 177,749 $10.43
9 Nov 2015

Vitullo (Nicole)

Director Sell 1,325 $10.43
8 Nov 2015

Vitullo (Nicole)

Director Sell 318,551 $10.01
8 Nov 2015

Vitullo (Nicole)

Director Sell 2,375 $10.01
24 Sep 2015

Vitullo (Nicole)

Director Sell 9,241 $8.22
24 Sep 2015

Vitullo (Nicole)

Director Sell 69 $8.22
17 Aug 2015

Vitullo (Nicole)

Director Sell 483,521 $0.00
17 Aug 2015

Vitullo (Nicole)

Director Buy 31,431 $0.00
13 Aug 2015

Vitullo (Nicole)

Director Sell 37,843 $7.51
20 May 2015

Vitullo (Nicole)

Director Sell 1,700,000 $0.00
20 May 2015

Vitullo (Nicole)

Director Buy 222,630 $0.00
22 Jan 2015

Fenton (Mary Kay)

Chief Financial Officer Buy 13,125 $4.00
22 Jan 2015

Fenton (Mary Kay)

Chief Financial Officer Sell 13,125 $16.00
20 Jan 2015

Deshpande (Milind S)

Chief Executive Officer Sell 100,000 $15.00
20 Jan 2015

Deshpande (Milind S)

Chief Executive Officer Buy 100,000 $3.02

Institutional Holders

% Shares Owned: 83.82%
# of Holders: 211
Total Shares Held: 114,568,159
3 Mo. Net Change: -3,433,778
# New Positions: 17
# Closed Positions: 24
# Increased Positions: 86
# Reduced Positions: 75
# Net Buyers: 11

Officers & Directors

Name Age Since Current Position

David Scheer

63 2010 Chairman of the Board

Milind Deshpande

59 2013 President, Chief Executive Officer, Director

Mary Fenton

51 2015 Chief Financial Officer, Executive Vice President

Joel Barrish

58 2016 Executive Vice President, Chief Scientific Officer

Martha Manning

61 2016 Executive Vice President, General Counsel, Corporate Secretary

David Apelian

50 2013 Executive Vice President, Chief Medical Officer

Joseph Truitt

51 2014 Executive Vice President, Chief Commercial Officer

Amy Jennings

2016 Senior Vice President - Regulatory Affairs

Michael Kishbauch

66 2013 Director

Frank Verwiel

54 2015 Director

Jason Fisherman

58 2000 Independent Director

Gary Frashier

78 2008 Independent Director

Kurt Graves

48 2012 Independent Director

Robert Van Nostrand

58 2007 Independent Director

Nicole Vitullo

58 2010 Independent Director